Obstructive Nephropathy Mechanisms and Biomarkers

Obstructive nephropathy arises when urinary tract blockage—partial or complete—leads to elevated intraluminal pressure, hypoxia, tubular cell injury and death, sterile inflammation and progressive interstitial fibrosis. Mechanical stress on tubular epithelial cells triggers release of damage-associated molecular patterns and activation of innate immune pathways, while adaptive responses involving cytokines, chemokines and infiltrating leucocytes amplify injury. Renin–angiotensin system dysregulation and oxidative stress further promote extracellular matrix deposition and nephron loss. Traditional measures such as serum creatinine and imaging are insensitive to early, unilateral damage. Recent advances in urinary and serum biomarkers—including neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, monocyte chemotactic protein 1 and various proteomic profiles—offer promise for early detection, prognostic assessment and therapeutic monitoring. An improved understanding of age-dependent immune regulation, programmed cell death pathways and molecular drivers of fibrosis is guiding development of targeted interventions to preserve renal architecture and function.

Research from Nature Portfolio

Recent studies have explored cytokine-mediated modulation of inflammation and programmed necrosis in experimental obstructive injury. In a neonatal model of ureteral obstruction, deficiency of the anti-inflammatory cytokine interleukin-10 was found to reduce early neutrophil and dendritic-cell infiltration, diminish pro-inflammatory chemokine release and attenuate necroptotic cell death without altering long-term fibrotic outcomes. This age-specific response highlights divergent roles of regulatory cytokines during kidney development and suggests windows for immunomodulatory therapy. Complementing this, investigation of necroptosis in neonatal obstruction revealed upregulation of receptor-interacting protein kinase 3 and mixed-lineage kinase domain-like protein alongside increased release of interleukin-1α and tumour necrosis factor-α. The linkage of necroptotic signalling to sterile inflammation underscores programmed necrosis as both a driver and potential biomarker of early tubular injury.

Obstructive Nephropathy Mechanisms and Biomarkers publication trend

The graph below shows the total number of articles in obstructive nephropathy mechanisms and biomarkers across all publications each year (not limited to Nature Index journals).

Technical terms

Unilateral ureteral obstruction (UUO): Experimental model in which one ureter is blocked to mimic obstructive nephropathy, leading to tubular injury and fibrosis.

Necroptosis: A form of programmed cell death mediated by RIPK3 and MLKL that induces inflammation through release of intracellular contents.

Damage-associated molecular patterns (DAMPs): Endogenous molecules released by injured cells that activate innate immune receptors and drive sterile inflammation.

Neutrophil gelatinase-associated lipocalin (NGAL): A small protein upregulated in injured tubular cells; serves as an early urinary biomarker of acute kidney injury.

Kidney injury molecule 1 (KIM-1): A transmembrane protein expressed on dedifferentiated tubular epithelium; its urinary form indicates proximal tubule damage.

Interstitial fibrosis: Accumulation of extracellular matrix proteins in the renal interstitium, leading to chronic loss of functional nephrons.

Cytokine: A signalling protein released by cells that influences inflammation, immune responses and cell survival.

References

1. Interleukin-10 enhances recruitment of immune cells in the neonatal mouse model of obstructive nephropathy. Scientific Reports (2024).
2. Neonatal obstructive nephropathy induces necroptosis and necroinflammation. Scientific Reports (2019).
3. Roles Played by Biomarkers of Kidney Injury in Patients with Upper Urinary Tract Obstruction. International Journal of Molecular Sciences (2020).
4. DAMPs in Unilateral Ureteral Obstruction. Frontiers in Immunology (2020).